Scoped technical review · 4 October 2026 Scope: default profile and shared integration only. Dated source reviews and isolated tests do not certify the whole overlay, live routing, privacy or current health. This is a staged preview, not an installation or publication.
Routing assurance — independently reviewed staged source PASS; inactive, not installed. Evidence includes synthetic boundary probes; no live disclosure was demonstrated. Declared endpoint locality is metadata, not network enforcement; grant provenance is not authenticated.Reporting contracts — independent bounded source-review PASS for terminal test-count framing and fixed diagnostic categories; inactive. Optional-component absence is inventory, not implementation coverage.Source-contract suite — 144/144 contracts passed; 1,695 test cases reported. Explicit delegation: 38 executed, 0 skipped. This separate parent run is not a live integration test.Health collector contracts — staging-contract PASS; live health remains unknown / nonzero . 2 medium live-integration gates remain open: receipt freshness/source policy, and live producer, database/scheduler coverage and loaded-byte attestation. Not deployment-ready.Synthetic delivery path — 2 tests passed through the scheduler, durable claim and recording delivery adapter. External workers and agent execution were replaced; enabled dispatch, real agent construction, full rollback/failure coverage and the post-delivery crash window were not certified.The ledger below and the 4 October delegation note remain historical documentation. Their original evidence dates and runtime claims have not been advanced or newly certified.
These dated notes are preserved from the reviewed preview. The historical ledger and delegation note remain on the storytelling page; “below” in the original block refers to that original layout.
Read the historical evidence →